CLASSYS Inc. (KOSDAQ:214150)
55,300
+200 (0.36%)
At close: Dec 5, 2025
CLASSYS Market Cap
CLASSYS has a market cap or net worth of 3.61 trillion as of December 5, 2025. Its market cap has increased by 7.10% in one year.
Market Cap
3.61T
Enterprise Value
3.53T
Revenue
317.80B
Ranking
n/a
PE Ratio
30.89
Stock Price
55,300.00
Market Cap Chart
Since December 13, 2017, CLASSYS's market cap has increased from 279.08B to 3.61T, an increase of 1,194.57%. That is a compound annual growth rate of 37.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 3.60T | 15.33% |
| Dec 30, 2024 | 3.12T | 28.96% |
| Dec 28, 2023 | 2.42T | 104.22% |
| Dec 29, 2022 | 1.19T | -2.59% |
| Dec 30, 2021 | 1.22T | 22.09% |
| Dec 30, 2020 | 996.52B | 9.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 13, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 77.77T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8.84T |
| LigaChem Biosciences | 7.14T |
| Peptron | 6.54T |